Patexia Logo
Patexia Logo
Products
  • IP Intelligence Reports
  • Patexia Concierge
  • Patent Analyzer
  • Trademarks Analyzer
  • Litigation Analyzer
  • All Products
Services
  • Lateral Opportunities
  • Expert Witness
  • Research Studies
  • Strategic Partnership
  • All Services
IP Community
  • IP Community
  • IP Webinars
  • In the News
Company
  • About Us
  • Press Release
  • Careers
  • Contact Us
Login
JoinBook a Meeting
Patexia Logo
Products
  • IP Intelligence Reports
  • Patexia Concierge
  • Patent Analyzer
  • Trademarks Analyzer
  • Litigation Analyzer
Services
  • Lateral Opportunities
  • Expert Witness
  • Research Studies
  • Strategic Partnership
Company
  • About Us
  • Press Release
  • Careers
  • Contact Us
Resources
  • IP Community
  • IP Webinars
  • In the News
  • Help Center
Contact
  • (310) 909-7611
  • 100 Wilshire Blvd. Suite 700
    Santa Monica, CA 90401 USA
  • info@patexia.com
  • Send a message
Follow Us
Terms and Conditions|Privacy Policy
© 2010-2023 Patexia Inc. All Rights Reserved.
Back to All Articles
Browse articles with tag: Novartis
You must be logged in to create a new article
All Articles
Bryan Wheelock
Apr 19, 2017
•
Featured
Just Because the Board Didn’t Say It, Doesn’t Mean that the Board Didn’t Think It
In Novartis AG v. Torrent Pharmaceuticals Limited, [2016-1352] (April 12, 2017), the Federal Circuit affirmed the PTAB’s determination that the... Read More
Valerie Clark
Apr 27, 2012
•
Featured
What one drug company is doing to increase health care costs
International pharmaceutical giant Novartis is suing the United Kingdom's national health system (NHS) for using a cheaper, unlicensed drug instead... Read More
Alejandro Freixes
Nov 1, 2011
ADHD drugs do not increase heart problems in kids
CHICAGO (Reuters) - Stimulants used to treat attention deficit hyperactivity disorder do not increase the risk of heart attacks, strokes... Read More
Alejandro Freixes
Oct 26, 2011
Biogen MS drug BG-12 meets goal of second trial
  By Toni Clarke               (Reuters) - Biogen Idec Inc's said on Wednesday its... Read More
Alejandro Freixes
Oct 26, 2011
World Intellectual Property Organization holds an innovation consortium
  GENEVA (Reuters) - The World Intellectual Property Organization launched a consortium on Wednesday that would allow the public and... Read More
Alejandro Freixes
Oct 25, 2011
Novartis, Vectura lung drugs face delay in U.S.
  LONDON (Reuters) - Two lung drugs being developed by Novartis and its British partner Vectura face delays in the United States, the Swiss... Read More